DL-Phenylalanine is marketed as a nutritional supplement for its reported analgesic and antidepressant activities.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| General health | 2 | 0 | |||||
| Other | 1 | 0 | |||||
| Support another treatment | 1 |
|
1 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
1 | 100% |
|
Report created on November 22, 2009.